Premium
A randomised, double‐blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin–noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine †
Publication year - 2015
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.2492
Subject(s) - vortioxetine , serotonin reuptake inhibitor , psychopharmacology , agomelatine , reuptake inhibitor , serotonin , psychology , major depressive disorder , psychiatry , medicine , mood , antidepressant , oncology , pharmacology , anxiety , receptor